Continuous Glucose Monitoring in Critically Ill Patients With COVID-19: Results of an Emergent Pilot Study.

Archana R SadhuIvan Alexander SerranoJiaqiong XuTariq NisarJessica LucierAnjani R PandyaBhargavi Patham

Published in: Journal of diabetes science and technology (2020)

During the COVID-19 pandemic, CGM is feasible in critically ill patients and has acceptable accuracy to identify trends and guide intermittent blood glucose monitoring with insulin therapy.

Keyphrases

type diabetes
high intensity
glycemic control
stem cells
metabolic syndrome
bone marrow
skeletal muscle